Abbott Laboratories
ABT
$88.76
$0.991.13%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.28B | 6.52B | 13.98B | 13.98B | 13.50B |
| Total Depreciation and Amortization | 3.16B | 3.12B | 3.13B | 3.14B | 3.17B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 757.00M | 729.00M | 1.14B | 1.14B | 1.14B |
| Change in Net Operating Assets | -732.00M | -803.00M | -9.13B | -9.22B | -8.86B |
| Cash from Operations | 9.46B | 9.57B | 9.12B | 9.04B | 8.95B |
| Capital Expenditure | -2.09B | -2.17B | -2.20B | -2.26B | -2.29B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -19.90B | -105.00M | -85.00M | -30.00M | -- |
| Divestitures | -- | -- | 0.00 | 0.00 | 1.00M |
| Other Investing Activities | -287.00M | -146.00M | -88.00M | -220.00M | -91.00M |
| Cash from Investing | -22.28B | -2.42B | -2.38B | -2.51B | -2.38B |
| Total Debt Issued | 19.90B | 5.00M | 4.00M | 5.00M | 224.00M |
| Total Debt Repaid | -2.00B | -1.62B | -2.16B | -1.63B | -1.67B |
| Issuance of Common Stock | 225.00M | 396.00M | 416.00M | 439.00M | 417.00M |
| Repurchase of Common Stock | -793.00M | -893.00M | -906.00M | -1.35B | -1.35B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.19B | -4.12B | -4.04B | -3.97B | -3.91B |
| Other Financing Activities | -82.00M | -82.00M | -82.00M | -82.00M | -- |
| Cash from Financing | 13.06B | -6.31B | -6.77B | -6.59B | -6.28B |
| Foreign Exchange rate Adjustments | 24.00M | 71.00M | -18.00M | 28.00M | -36.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 271.00M | 906.00M | -47.00M | -36.00M | 248.00M |